Search for a trial

The Baerveldt Implant.
Is postoperative ocular motility improved when conventional securing to the sclera is omitted?

To monitor the effect of the free plate technique in Baerveldt implant surgery on the postoperative eye motility.

Post market study to evaluate safety and effectiveness of the InnFocus MicroShunt® (MIDI Arrow) in patients with primary open angle glaucoma

The purpose of this study is to collect additional safety and effectiveness of the InnFocus MicroShunt (MIDI Arrow) in subjects suffering from primary open angle glaucoma that are inadequately controlled on maximum tolerated medical therapy with…

Trabeculectomy with Ologen®-Pilot

The primary objective is the degree of IOP lowering after trabeculectomy with adjuvant Ologen® implantation, in comparison to trabeculectomy with mitomycin-C. Secondary objectives are peroperative and postoperative complications, and postoperative…

Primary Baerveldt glaucoma implant versus trabeculectomy study.

Demonstrate that compared to trabeculectomy, at 12 months follow-up:- a Baerveldt implant is not inferior with respect to IOP and- a Baerveldt implant is superior with respect to failure.

THE HYDRUS II TRIAL:
A PROSPECTIVE, MULTICENTER, RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE
SAFETY AND EFFECTIVENESS OF THE HYDRUS IMPLANT FOR LOWERING INTRAOCULAR PRESSURE IN GLAUCOMA PATIENTS UNDERGOING CATARACT SURGERY

The purpose of this study is to expand knowledge of the IVANTIS Hydrus Implant's ability to decrease intraocular pressure (the pressure in the eye).

A tilt-detector for the Xal-Ease eye drops delivery aid.
Usability and patient satisfaction.

Part 1: To determine the effectiveness of self-instillation of fluorescein drops by means of the combined E-Box/Xal-Ease device. Part 2: To determine patient satisfaction of the two administration procedures, i.e. Xal-Ease versus E-Box/Xal-Ease.

PACT GLAUCOMA TREATMENT OF THE CORNEA SCLERAL TISSUE.

The purpose of this clinical trial is to evaluate the clinical performance of the PACT procedure in lowering intra-ocular pressure in subjects with elevated intra-ocular pressure, as a function of glaucoma or ocular hypertension.

A Prospective, Concurrent Controlled, Open-Label, Multicenter Clinical Study to Assess the Long-Term Safety of the PRESERFLO® MicroShunt in Subjects with Primary Open-Angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study.

The purpose of this study is to evaluate the long-term safety of the PRESERFLO® MicroShunt in subjects with Primary Open-Angle Glaucoma who have completed participation in the INN-005 clinical study, conducted under IDE G130028, by collecting safety…